Tarsus Pharmaceuticals Market Sentiment

Tarsus Pharmaceuticals Inc

TARSNASDAQ

Trade with Public

$72.29

1.472.08%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Tarsus Pharmaceuticals Market Sentiment - Benzinga

Tarsus Pharmaceuticals Market Sentiment

Market sentiment signals for Tarsus Pharmaceuticals (TARS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 13.4% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

—

Avg Consensus PT

$89

+23.2%

Highest Price Target

$116

+60.5%

Goldman Sachs

Lowest Price Target

$51

-29.5%

Goldman Sachs

Short Interest

13.4%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+60.5%	$116	Reinstates	Buy
Sep 16, 2026	Barclays	Glen Santangelo—	+52.2%	$110	Reinstates	Overweight
Sep 8, 2026	Jefferies	Anthony Petrone—	+45.2%	$88 → $105	Maintained	Buy
Aug 12, 2026	Oppenheimer	Francois Brisebois—	+38.3%	$97 → $100	Maintained	Outperform
Jul 31, 2026	Mizuho	Graig Suvannavejh—	+35.6%	$100 → $98	Maintained	Outperform
Jul 21, 2026	Guggenheim	Brad Canino—	+23.1%	$90 → $89	Maintained	Buy
Jul 9, 2026	HC Wainwright & Co.	Matthew Caufield—	+21.7%	$88 → $88	Maintained	Buy
May 4, 2026	HC Wainwright & Co.	Matthew Caufield—	+21.7%	$88 → $88	Maintained	Buy
Feb 25, 2026	Oppenheimer	Francois Brisebois—	+45.2%	$95 → $105	Maintained	Outperform
Feb 25, 2026	Guggenheim	Eddie Hickman—	+24.5%	$87 → $90	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	+38.3%	$100	Initiate	Overweight
Nov 20, 2025	Mizuho	Graig Suvannavejh—	+38.3%	$100	Initiate	Outperform
Nov 5, 2025	Guggenheim	Eddie Hickman—	+20.3%	$84 → $87	Maintained	Buy
Oct 20, 2025	HC Wainwright & Co.	Matthew Caufield—	+21.7%	$72 → $88	Maintained	Buy
May 27, 2025	HC Wainwright & Co.	Matthew Caufield—	-0.4%	$72	Assumes	Buy
May 5, 2025	Goldman Sachs	Andrea Tan—	-29.5%	$46 → $51	Maintained	Neutral
May 2, 2025	Guggenheim	Eddie Hickman—	+16.2%	$78 → $84	Maintained	Buy
Mar 6, 2025	Jefferies	Anthony Petrone—	-19.8%	$54 → $58	Maintained	Buy
Feb 26, 2025	Guggenheim	Eddie Hickman—	+7.9%	$75 → $78	Maintained	Buy
Feb 26, 2025	HC Wainwright & Co.	Oren Livnat—	+1.0%	$73 → $73	Maintained	Buy
Feb 26, 2025	Barclays	Balaji Prasad—	-17.0%	$62 → $60	Maintained	Overweight
Feb 24, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Feb 10, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Jan 27, 2025	Barclays	Balaji Prasad—	-14.2%	$60 → $62	Maintained	Overweight
Jan 22, 2025	Oppenheimer	Francois Brisebois—	-0.4%	$65 → $72	Maintained	Outperform